NCT01222637View on ClinicalTrials.gov

CetuGEX™: Phase 1 Study in Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

October 31, 2013

Conditions
Solid Tumors
Interventions
DRUG

CetuGEX™

Trial Locations (5)

20132

Glycotope Investigational Site, Milan

20133

Glycotope Investigational Site, Milan

D-20246

Glycotope Investigational Site, Hamburg

D-69120

Glycotope Investigational Site, Heidelberg

CH-6500

Glycotope Investigational Site, Bellinzona

Sponsors

Lead Sponsor

Glycotope GmbH
All Listed Sponsors
lead

Glycotope GmbH

INDUSTRY